BridgeMD
New treatment option for Ischemic Stroke
Official title the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
ClinicalTrials.gov ID: NCT06653946
What this study is testing
What is Alteplase?
Alteplase is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for ischemic stroke.
Also referred to as group A.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- The investigators enrolled individuals of both genders, aged between 18 and 75,
- All patients had acute first-ever embolic ischemic stroke and were eligible for thrombolysis.
- All patients had Atrial fibrillation
You likely can't join if
- The investigators excluded patients who had alteplase contraindications
- The investigators excluded patients who did not receive the total dose of alteplase for any reason.
- The investigators excluded patients who had a known history of persistent or recurrent CNS pathology (e.g., epilepsy, meningioma, multiple sclerosis)
- The investigators excluded patients who had recurrent ischemic stroke diagnosed by appropriate clinical history and/or MRI brain findings.
- The investigators excluded patients with symptoms of major organ failure, active malignancies, or an acute myocardial infarction within the previous...
- The investigators also excluded pregnant and lactating patients with stroke due to venous thrombosis and stroke following cardiac arrest.
The study team makes the final eligibility decision.
Where it's taking place
- Kafr ash Shaykh, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kafr ash Shaykh, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.